Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
Primary objective: To examine whether the switch to paliperidone ER from risperidone improves
cognitive function in stabilized patients with schizophrenia.
Secondary objectives: To compare the general clinical outcomes (efficacy and safety) after
switching to paliperidone ER from risperidone
Phase:
Phase 4
Details
Lead Sponsor:
Chonnam National University Hospital
Collaborators:
Janssen Korea, Ltd., Korea Ministry of Health, Republic of Korea